Vicore Pharma Holding AB (publ) VICO.ST Stock
Vicore Pharma Holding AB (publ) Price Chart
Vicore Pharma Holding AB (publ) VICO.ST Financial and Trading Overview
| Vicore Pharma Holding AB (publ) stock price | 17.6 SEK |
| Previous Close | 18.06 SEK |
| Open | 18.14 SEK |
| Bid | 18.06 SEK x 0 |
| Ask | 18.18 SEK x 0 |
| Day's Range | 18 - 18.26 SEK |
| 52 Week Range | 13.5 - 35.45 SEK |
| Volume | 26.9K SEK |
| Avg. Volume | 311.71K SEK |
| Market Cap | 1.49B SEK |
| Beta (5Y Monthly) | 0.582758 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.22 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 61.67 SEK |
VICO.ST Valuation Measures
| Enterprise Value | 1.29B SEK |
| Trailing P/E | N/A |
| Forward P/E | -5.416667 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.632653 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -5.004 |
Trading Information
Vicore Pharma Holding AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.582758 |
| 52-Week Change | -40.98% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 35.45 SEK |
| 52 Week Low | 13.5 SEK |
| 50-Day Moving Average | 20.01 SEK |
| 200-Day Moving Average | 21.76 SEK |
VICO.ST Share Statistics
| Avg. Volume (3 month) | 311.71K SEK |
| Avg. Daily Volume (10-Days) | 335.92K SEK |
| Shares Outstanding | 81.85M |
| Float | 49.77M |
| Short Ratio | N/A |
| % Held by Insiders | 16.76% |
| % Held by Institutions | 59.40% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -51.0059% |
| Return on Equity (ttm) | -101.32% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -258726000 SEK |
| Net Income Avi to Common (ttm) | -261336000 SEK |
| Diluted EPS (ttm) | -3.47 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 183.63M SEK |
| Total Cash Per Share (mrq) | 2.24 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 5.288 |
| Book Value Per Share (mrq) | 2.744 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -305969984 SEK |
| Levered Free Cash Flow (ttm) | -210447008 SEK |
Profile of Vicore Pharma Holding AB (publ)
| Country | Sweden |
| State | N/A |
| City | Stockholm |
| Address | Kornhamnstorg 53 |
| ZIP | SE-111 27 |
| Phone | 46 31 788 05 60 |
| Website | https://www.vicorepharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 25 |
Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company's portfolio includes idiopathic pulmonary fibrosis (IPF) and pulmonary arterial hypertension (PAH) diseases. The company develops C21, a low molecular weight angiotensin II type 2 receptor agonist ATRAG; Almee, an investigational medical device in clinical development to address the psychological impact of living with pulmonary fibrosis; Inhaled IMID for the severe cough associated with IPF; and C103, C111, and C112. It has a collaboration and development agreement with Emeriti Bio AB. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is based in Stockholm, Sweden.
Q&A For Vicore Pharma Holding AB (publ) Stock
What is a current VICO.ST stock price?
Vicore Pharma Holding AB (publ) VICO.ST stock price today per share is 17.6 SEK.
How to purchase Vicore Pharma Holding AB (publ) stock?
You can buy VICO.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Vicore Pharma Holding AB (publ)?
The stock symbol or ticker of Vicore Pharma Holding AB (publ) is VICO.ST.
Which industry does the Vicore Pharma Holding AB (publ) company belong to?
The Vicore Pharma Holding AB (publ) industry is Biotechnology.
How many shares does Vicore Pharma Holding AB (publ) have in circulation?
The max supply of Vicore Pharma Holding AB (publ) shares is 111.72M.
What is Vicore Pharma Holding AB (publ) Price to Earnings Ratio (PE Ratio)?
Vicore Pharma Holding AB (publ) PE Ratio is now.
What was Vicore Pharma Holding AB (publ) earnings per share over the trailing 12 months (TTM)?
Vicore Pharma Holding AB (publ) EPS is -3.22 SEK over the trailing 12 months.
Which sector does the Vicore Pharma Holding AB (publ) company belong to?
The Vicore Pharma Holding AB (publ) sector is Healthcare.
Vicore Pharma Holding AB (publ) VICO.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| OMX Stockholm All-Share Cap_GI OMXSCAPGI | 456.92 SEK 44.6 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_ISK_GI OMXNSCISKGI | 517.93 ISK 3.81 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_DKK_GI OMXNSCDKKGI | 349.16 DKK 51.19 USD |
-0.69
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden PI NOMXSCSEPI | 2564.43 SEK 250.32 USD |
-0.59
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX4000PI | 2712.52 SEK 264.78 USD |
<0.01
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care GI SX20GI | 4204.43 SEK 410.4 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030GI | 6954.45 SEK 678.84 USD |
+0.49
|
— — | — — | — — | — - | — — |
| OMX_Stockholm_Small_Cap_GI OMXSSCGI | 596.42 SEK 58.22 USD |
-0.19
|
— — | — — | — — | — - | — — |
| OMX Stockholm_GI OMXSGI | 466.5 SEK 45.54 USD |
+0.02
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_SEK_GI OMXNSCSEKGI | 435.1 SEK 42.47 USD |
-0.21
|
— — | — — | — — | — - | — — |
| OMX_Nordic_Small_Cap_EUR_GI OMXNSCEURGI | 349.01 EUR 381.52 USD |
-0.71
|
— — | — — | — — | — - | — — |
| OMX Affarsvarldens Generalindex OMXAFGX | 923.83 SEK 90.18 USD |
-0.03
|
— — | — — | — — | — - | — — |
| NASDAQ OMX Small Cap Sweden GI NOMXSCSEGI | 4086.93 SEK 398.94 USD |
-0.47
|
— — | — — | — — | — - | — — |
| OMX Stockholm Health Care PI SX20PI | 3276.93 SEK 319.87 USD |
-0.07
|
— — | — — | — — | — - | — — |
| OMX Stockholm Pharmaceuticals a SX201030PI | 5132.25 SEK 500.97 USD |
+0.49
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}